You searched for "email"
SightCare 'The Future is Now' Conference a Success
SightCare, the business support community for independent practices, was held on 29 and 30 January 2023 after its postponement from its original September date which unfortunately fell on the day of the Queen’s funeral.
RaScaL Study
The RaScaL study was a six month, single-centre, controlled, prospective phase I/II study in which subjects with diabetic macular oedema (DME) and associated peripheral nonperfusion on ultrawide-field fluorescein angiography (UWFA) were randomised to: (1) study arm: ranibizumab (0.5 mg) injection...Spectacle Makers' Charity: Student Bursary Scheme opens for 2024-25 academic year
The Spectacle Makers’ Charity has this week opened applications for student bursaries for the 2024-25 academic year. Since launch, the bursary scheme has helped more than 120 students enrolled on degree and diploma courses in dispensing, orthoptics, optometry, ophthalmic imaging...
The natural history of treatment naïve choroidal neovascularisation (CNV) in geographic atrophy
The aim of this retrospective study is to assess the characteristics and natural history of quiescent CNV in geographic atrophy (GA) utilising multi-modal imaging. Case notes were reviewed of patients diagnosed with geographic atrophy between January 2010 and December 2016...
Cataract surgery in small adult eyes
This is a retrospective audit of a five year study period, between the periods of January 2006 to December 2010, where a surgical log book search was performed. The inclusion criteria of this study were intraocular lenses (IOL) power greater...
Microvasculature changes of mCNV after ranibizumab treatment using OCTA
In this study the authors aim to evaluate the vascular changes of myopic choroidal neovascularisation (mCNV) after ranibizumab treatment using optical coherence tomography-angiography (OCTA). The 3×3 OCTA en face images were analysed for the absence / presence of mCNV, CNV...
